Crystal structure of protein C inhibitor provides insights into hormone binding and heparin activation

Structure

Volumn 11, Issue 2, 2003, Pages 205-215

  Huntington, James A ^a   Kjellberg, Margareta ^b   Stenflo, Johan ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Heparin; Inhibitor; Protease; Retinoid; Serpin; Thrombin

Indexed keywords

HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 3; RETINOIC ACID; RETINOID;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; ELECTRICITY; HORMONE BINDING; HYDROPHOBICITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SURFACE PROPERTY; X RAY CRYSTALLOGRAPHY;

BINDING SITES; CRYSTALLOGRAPHY, X-RAY; HEPARIN; PROTEIN BINDING; PROTEIN C INHIBITOR; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RETINOIDS;

EID: 0037314019     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(02)00944-9     Document Type: Article

References (65)

1. Geiger M., Zechmeister-Machhart M., Uhrin P., Hufnagl P., Ecke S., Priglinger U., Xu J., Zheng X., Binder B.R. Protein C inhibitor (PCI). Immunopharmacology. 32:1996;53-56.
2. Rezaie A.R., Cooper S.T., Church F.C., Esmon C.T. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J. Biol. Chem. 270:1995;25336-25339.
3. Espana F., Berrettini M., Griffin J.H. Purification and characterization of plasma protein C inhibitor. Thromb. Res. 55:1989;369-384.
4. Geiger M., Huber K., Wojta J., Stingl L., Espana F., Griffin J.H., Binder B.R. Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivo. Blood. 74:1989;722-728.
5. Espana F., Estelles A., Fernandez P.J., Gilabert J., Sanchez-Cuenca J., Griffin J.H. Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma. Thromb. Haemost. 70:1993;989-994.
6. Laurell M., Stenflo J. Protein C inhibitor from human plasma. characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein Thromb. Haemost. 62:1989;885-891.
7. Espana F., Fink E., Sanchez-Cuenca J., Gilabert J., Estelles A., Witzgall K. Complexes of tissue kallikrein with protein C inhibitor in human semen and urine. Eur. J. Biochem. 234:1995;641-649.
8. Ecke S., Geiger M., Resch I., Jerabek I., Sting L., Maier M., Binder B.R. Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein. J. Biol. Chem. 267:1992;7048-7052.
9. Ecke S., Geiger M., Binder B.R. Glycosaminoglycans regulate the enzyme specificity of protein C inhibitor. Ann. N Y Acad. Sci. 667:1992;84-86.
10. Ecke S., Geiger M., Binder B.R. Heparin binding of protein-C inhibitor - analysis of the effect of heparin on the interaction of protein-C inhibitor with tissue kallikrein. Eur. J. Biochem. 248:1997;475-480.
11. Ecke S., Geiger M., Resch I., Jerabek I., Maier M., Binder B.R. Possible identity of kallikrein binding protein with protein C inhibitor. Agents Actions Suppl. 38:1992;182-189.
12. Huntington J.A., Read R.J., Carrell R.W. Structure of a serpin-protease complex shows inhibition by deformation. Nature. 407:2000;923-926.
13. Huntington J.A., Carrell R.W. The serpins. nature's molecular mousetraps Sci. Prog. 84:1901;125-136.
14. Neese L.L., Wolfe C.A., Church F.C. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor. Arch. Biochem. Biophys. 355:1998;101-108.
15. Shirk R.A., Elisen M.G., Meijers J.C., Church F.C. Role of the H helix in heparin binding to protein C inhibitor. J. Biol. Chem. 269:1994;28690-28695.
16. Kazama Y., Niwa M., Yamagishi R., Takahashi K., Sakuragawa N., Koide T. Specificity of sulfated polysaccharides to accelerate the inhibition of activated protein C by protein C inhibitor. Thromb. Res. 48:1987;179-185.
17. Olson S.T., Bjork I. Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects. J. Biol. Chem. 266:1991;6353-6364.
18. Espana F., Gilabert J., Estelles A., Romeu A., Aznar J., Cabo A. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb. Res. 64:1991;309-320.
19. Hermans J.M., Jones R., Stone S.R. Rapid inhibition of the sperm protease acrosin by protein C inhibitor. Biochemistry. 33:1994;5440-5444.
20. Zheng X., Geiger M., Ecke S., Bielek E., Donner P., Eberspacher U., Schleuning W.D., Binder B.R. Inhibition of acrosin by protein C inhibitor and localization of protein C inhibitor to spermatozoa. Am. J. Physiol. 267:1994;C466-C472.
21. Uhrin P., Dewerchin M., Hilpert M., Chrenek P., Schofer C., Zechmeister-Machhart M., Kronke G., Vales A., Carmeliet P., Binder B.R.et al. Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility. J. Clin. Invest. 106:2000;1531-1539.
22. Jerabek I., Zechmeister-Machhart M., Binder B.R., Geiger M. Binding of retinoic acid by the inhibitory serpin protein C inhibitor. Eur. J. Biochem. 268:2001;5989-5996.
23. Pemberton P.A., Stein P.E., Pepys M.B., Potter J.M., Carrell R.W. Hormone binding globulins undergo serpin conformational change in inflammation. Nature. 336:1988;257-258.
24. Suda S.A., Gettins P.G., Patston P.A. Linkage between the hormone binding site and the reactive center loop of thyroxine binding globulin. Arch. Biochem. Biophys. 384:2000;31-36.
25. Janssen O.E., Golcher H.M., Grasberger H., Saller B., Mann K., Refetoff S. Characterization of T(4)-binding globulin cleaved by human leukocyte elastase. J. Clin. Endocrinol. Metab. 87:2002;1217-1222.
26. Huber R., Carrell R.W. Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry. 28:1989;8951-8966.
27. Edgar P., Stein P. Hormone binding site of corticosteroid binding globulin. Nat. Struct. Biol. 2:1995;196-197.
28. Simonovic M., Gettins P.G.W., Volz K. Crystal structure of viral serpin crmA provides insights into its mechanism of cysteine proteinase inhibition. Protein Sci. 9:2000;1423-1427.
29. Renatus M., Zhou Q., Stennicke H.R., Snipas S.J., Turk D., Bankston L.A., Liddington R.C., Salvesen G.S. Crystal structure of the apoptotic suppressor CrmA in its cleaved form. Struct. Fold. Des. 8:2000;789-797.
30. Cardin A.D., Weintraub H.J. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis. 9:1989;21-32.
31. Kuhn L.A., Griffin J.H., Fisher C.L., Greengard J.S., Bouma B.N., Espana F., Tainer J.A. Elucidating the structural chemistry of glycosaminoglycan recognition by protein C inhibitor. Proc. Natl. Acad. Sci. USA. 87:1990;8506-8510.
32. Loebermann H., Tokuoka R., Deisenhofer J., Huber R. Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J. Mol. Biol. 177:1984;531-557.
33. Olson S.T., Swanson R., Day D., Verhamme I., Kvassman J., Shore J.D. Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin. Biochemistry. 40:2001;11742-11756.
34. Jin L., Abrahams J.P., Skinner R., Petitou M., Pike R.N., Carrell R.W. The anticoagulant activation of antithrombin by heparin. Proc. Natl. Acad. Sci. USA. 94:1997;14683-14688.
35. Chuang Y.J., Swanson R., Raja S.M., Olson S.T. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin. J. Biol. Chem. 276:2001;14961-14971.
36. Petitou M., Herault J.P., Bernat A., Driguez P.A., Duchaussoy P., Lormeau J.C., Herbert J.M. Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature. 398:1999;417-422.
37. Ye S., Chech A.L., Belmares R., Bergstrom R.C., Tong Y., Corey D.R., Kanost M.R., Goldsmith E.J. The structure of a Michaelis serpin-protease complex. Nat. Struct. Biol. 8:2001;979-983.
38. Baglin T.P., Carrell R.W., Church F.C., Esmon C.T., Huntington J.A. Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. Proc. Natl. Acad. Sci. USA. 99:2002;11079-11084.
39. Peterson F.C., Gordon N.C., Gettins P.G. Formation of a noncovalent serpin-proteinase complex involves no conformational change in the serpin. Use of 1H-15N(HSQC NMR as a sensitive nonperturbing monitor of conformation. Biochemistry 39):2000;11884-11892.
40. Fujita M., Izutani W., Takahashi K., Nishizawa K., Shirono H., Koga J. Role of each Asn-linked glycan in the anticoagulant activity of human protein C inhibitor. Thromb. Res. 105:2002;95-102.
41. Shen L., Villoutreix B.O., Dahlback B. Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor. Thromb. Haemost. 82:1999;72-79.
42. Yang L., Manithody C., Rezaie A.R. Contribution of basic residues of the 70-80-loop to heparin binding and anticoagulant function of activated protein C. Biochemistry. 41:2002;6149-6157.
43. Friedrich U., Blom A.M., Dahlback B., Villoutreix B.O. Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C. J. Biol. Chem. 276:2001;24122-24128.
44. Aznar J., Espana F., Estelles A., Royo M. Heparin stimulation of the inhibition of activated protein C and other enzymes by human protein C inhibitor - influence of the molecular weight of heparin and ionic strength. Thromb. Haemost. 76:1996;983-988.
45. Rezaie A.R., Olson S.T. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies. Biochemistry. 39:2000;12083-12090.
46. Liaw P.C., Austin R.C., Fredenburgh J.C., Stafford A.R., Weitz J.I. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II. J. Biol. Chem. 274:1999;27597-27604.
47. Olson S.T., Halvorson H.R., Bjork I. Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models. J. Biol. Chem. 266:1991;6342-6352.
48. Avvakumov G.V., Hammond G.L. Substitutions of tryptophan residues in human corticosteroid-binding globulin. impact on steroid binding and glycosylation J. Steroid Biochem. Mol. Biol. 49:1994;191-194.
49. Emptoz-Bonneton A., Cousin P., Seguchi K., Avvakumov G.V., Bully C., Hammond G.L., Pugeat M. Novel human corticosteroid-binding globulin variant with low cortisol-binding affinity. J. Clin. Endocrinol. Metab. 85:2000;361-367.
50. Smith C.L., Power S.G., Hammond G.L. A Leu → His substitution at residue 93 in human corticosteroid binding globulin results in reduced affinity for cortisol. J. Steroid Biochem. Mol. Biol. 42:1992;671-676.
51. Perini J.M., Le Gaillard F., Aubert J.P., Dautrevaux M. Importance of arginine residues in the determination of the biological activity of human corticosteroid-binding globulin. Biochimie. 65:1983;579-583.
52. Laurell M., Carlson T.H., Stenflo J. Monoclonal antibodies against the heparin-dependent protein C inhibitor suitable for inhibitor purification and assay of inhibitor complexes. Thromb. Haemost. 60:1988;334-339.
53. Schechter I., Berger A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27:1967;157-162.
54. Strandberg K., Kjellberg M., Erb E.M., Persson U., Mosher D.F., Villoutreix B.O., Stenflo J. Activated protein C-protein C inhibitor complex formation. characterization of a neoepitope provides evidence for extensive insertion of the reactive center loop Biochemistry. 39:2000;15713-15720.
55. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
56. Vagin A., Teplyakov A. An approach to multi-copy search in molecular replacement. Acta Crystallogr. D Biol. Crystallogr. 56:2000;1622-1624.
57. Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer. an environment for comparative protein modeling Electrophoresis. 18:1997;2714-2723.
58. Brunger A.T., Adams P.D., Clore G.M., Delano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S.et al. Crystallography and NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54:1998;905-921.
59. Pannu N.S., Read R.J. Improved structure refinement through maximum likelihood. Acta Cyrstallogr. A. 52:1996;659-668.
60. McRee D.E. A visual protein crystallographic software system for X11/XView. J. Mol. Graph. 10:1992;44-46.
61. Kraulis P.J. Molscript - a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:1991;946-950.
62. Esnouf R.M. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. Model. 15:1997;132-134. 112-113.
63. Merritt E.A., Murphy M.E.P. Raster3d version-2.0 - a program for photorealistic molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 50:1994;869-873.
64. Hart T.N., Ness S.R., Read R.J. Critical evaluation of the research docking program for the CASP2 challenge. Proteins Suppl. 1:1997;205-209.
65. Gasteiger J., Rudolph C., Sadowski J. Automatic generation of 3D-atomic coordinates for organic molecules. Tetrahedron Comput. Methodol. 3:1990;537-547.